Andrew J. Gifford
Randwick, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumors.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2026
BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: October 26, 2025
High-throughput 3D engineered paediatric tumour models for precision medicine.
Journal: Molecular systems biology
Published: August 13, 2025
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young.
Journal: Molecular cancer therapeutics
Published: July 01, 2025
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.
Journal: Molecular cancer therapeutics
Published: July 01, 2025
Precision-guided therapy in H3K27-altered diffuse midline glioma.
Journal: Nature communications
Published: May 30, 2025
Working with Miraculous Mice: Mus musculus as a Model Organism.
Journal: Current protocols
Published: October 22, 2024
The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia.
Journal: HemaSphere
Published: October 02, 2024
The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia.
Journal: Blood cancer journal
Published: September 08, 2024
Returning raw genomic data to research participants in a pediatric cancer precision medicine trial.
Journal: NPJ genomic medicine
Published: May 02, 2024
Last Updated: 09/26/2026